Emerging Pathogen Preparedness Program Authorization Act
Official title: A bill to establish an emerging pathogen preparedness program within the Food and Drug Administration to improve regulatory oversight of medical countermeasures for future pandemics.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Emerging Pathogen Preparedness Program Authorization Act
This bill establishes a program in the Food and Drug Administration's Center for Biologics Evaluation and Research to support the development and approval of biological countermeasures. Authorized activities include the development of quality measures for countermeasures, surveillance programs to monitor countermeasures, and research and development of platform vaccine technology to support emergency use authorization requests.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2329: Emerging Pathogen Preparedness Program Authorization Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-2329/
"S. 2329: Emerging Pathogen Preparedness Program Authorization Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2329/.
S. 2329, 118th Cong. (2026), https://openamerica.io/bill/118-S-2329/.
[S. 2329: Emerging Pathogen Preparedness Program Authorization Act](https://openamerica.io/bill/118-S-2329/)